glp 1 drugs and ulcerative colitis Primer: The Skinny on GLP-1s Semaglutide and Ulcerative Colitis: Safety

[24] In 2020, the FDA approved two higher doses of the medication, 3.0 mg and 4.5 mg, based on results of the AWARD-11 trial demonstrating improved glucose lowering and weight benefits

Found works with insurers like Aetna, Cigna, and Blue Cross Blue Shield but does not currently accept Medicare or Medicaid

Reasons for Discontinuing GLP-1 Use Lapsed weight loss users said price and insurance coverage were the top reasons for discontinuing use

employing terms like Type 2 diabetes mellitus (T2DM), DPP4 inhibitors, and Dipeptidyl peptidase4, etc

( 10.1002/oby.21629) [DOI] [PMC free article] [PubMed] [Google Scholar] 17.Frias JP, Bonora E, Nevarez Ruiz L, Li YG, Yu Z, Milicevic Z, Malik R, Bethel MA, Cox DA

Understanding these dynamics gives us better insight into how GLP-1 works